GLAUCOMA 360

2020 vision: The future of ophthalmology (Part IV)

In this fourth installment on "2020 vision," pharmaceutical representatives share their outlook on what lies ahead for glaucoma innovations within the ophthalmic space.

Assessing the angle: Getting back to basics

How gonioscopy can offer ophthalmologists an option in treating patients with glaucoma

Developing a new therapy: Where do we go from here?

Researchers must weigh emotional, financial, and reputational considerations

Traditional glaucoma surgery in the era of MIGS procedures

July 28, 2020

Trabeculectomy may offer better results with more severe glaucoma

Apps now online to aid patients with visual impairment

July 27, 2020

Technology is off to a good start, but improvements still needed

OCTA: The jury is still out

July 24, 2020

Diagnostic and monitoring advances in glaucoma need fine-tuning

Funding new technologies for glaucoma treatment

July 23, 2020

With an eye on innovation, money is driving research of new therapies and devices.

Glaucoma drug delivery devices enter new frontier

July 22, 2020

Industry develops creative approaches to help increase patient medication adherence

Glaucoma devices: Now and in the future

July 21, 2020

Panel discusses IOP monitoring, drug delivery, data collection

Glaucoma 360: Lowering IOP using the MIMS solution

July 19, 2020

ICYMI: Nir Israeli, co-founder and CEO of Sanoculis discusses the company's new alternative surgical procedure for glaucoma designed to create a single-patient-use sterile tool and a multi-use external machine.